Rapid CEA test GECEA series

colorectal cancerbloodserum

The CEA Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of CEA in whole blood, serum or plasma. It is intended as an aid in the assessment and diagnosis of colorectal cancer and other types of cancer, such as pancreatic, stomach, breast, lung and certain types of thyroid and ovarian cancer. The CEA rapid test device utilizes a combination of colloidal gold conjugate and monoclonal antibodies to selectively detect elevated levels of CEA. CEA is present in high concentrations during fetal development, but ceases after birth. Therefore, it is not usually present in the blood of healthy adults. The normal CEA range for a non-smoking adult is less than 2.5 ng/mL and less than 5.0 ng/mL in a smoker. Features Two band results for simple interpretation Detects carcinoembryonic antigen Room temperature storage or refrigerated (2-30⁰C) Internal control included Reagents included Specifications Cut-off: 5 ng/mL Shelf Life: 24 months from the date of manufacture